Treatment of <i>Candida glabrata</i> Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
ABSTRACT While Candida albicans remains the most common Candida isolate, Candida glabrata accounts for approximately 15 to 20% of all Candida infections in the United States. In this study we used immunosuppressed mice infected with C. glabrata to investigate the efficacy of liposomal amphotericin B...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | Jon Olson, Jill Adler‐Moore, Peter J. Smith, Richard T. Proffitt |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Αγγλικά |
Έκδοση: |
2005
|
Διαθέσιμο Online: | https://doi.org/10.1128/aac.49.12.4895-4902.2005 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Treatment of Candida glabrata Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
από: Olson, Jon A., κ.ά.
Έκδοση: (2005) -
Caspofungin in Combination with Amphotericin B against Candida glabrata
από: Barchiesi, Francesco, κ.ά.
Έκδοση: (2005) -
Killing Kinetics of Caspofungin, Micafungin, and Amphotericin B against Candida guilliermondii
από: Cantón, Emilia, κ.ά.
Έκδοση: (2006) -
Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
από: Yamada, Shoko Merrit, κ.ά.
Έκδοση: (2016) -
Candida glabrata Mutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility
από: Healey, Kelley R., κ.ά.
Έκδοση: (2011)